SK91694A3 - Spray-cooled nabumetone, method of its preparation and use - Google Patents

Spray-cooled nabumetone, method of its preparation and use Download PDF

Info

Publication number
SK91694A3
SK91694A3 SK916-94A SK91694A SK91694A3 SK 91694 A3 SK91694 A3 SK 91694A3 SK 91694 A SK91694 A SK 91694A SK 91694 A3 SK91694 A3 SK 91694A3
Authority
SK
Slovakia
Prior art keywords
nabumetone
spray
cooled
tablet
dosage form
Prior art date
Application number
SK916-94A
Other languages
English (en)
Slovak (sk)
Inventor
Graham Stanley Leonard
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of SK91694A3 publication Critical patent/SK91694A3/sk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00—Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/20—Unsaturated compounds containing keto groups bound to acyclic carbon atoms
    • C07C49/255—Unsaturated compounds containing keto groups bound to acyclic carbon atoms containing ether groups, groups, groups, or groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1688—Processes resulting in pure drug agglomerate optionally containing up to 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Rheumatology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coating By Spraying Or Casting (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Road Signs Or Road Markings (AREA)
  • Catching Or Destruction (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Freezing, Cooling And Drying Of Foods (AREA)
  • Sampling And Sample Adjustment (AREA)
SK916-94A 1992-01-29 1993-01-22 Spray-cooled nabumetone, method of its preparation and use SK91694A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB929201857A GB9201857D0 (en) 1992-01-29 1992-01-29 Novel compound
PCT/GB1993/000145 WO1993014747A1 (en) 1992-01-29 1993-01-22 Spray-chilled nabumetone

Publications (1)

Publication Number Publication Date
SK91694A3 true SK91694A3 (en) 1995-03-08

Family

ID=10709436

Family Applications (1)

Application Number Title Priority Date Filing Date
SK916-94A SK91694A3 (en) 1992-01-29 1993-01-22 Spray-cooled nabumetone, method of its preparation and use

Country Status (24)

Country Link
US (1) US5539000A (cs)
EP (1) EP0624087B1 (cs)
JP (1) JPH07503245A (cs)
KR (1) KR950700056A (cs)
CN (1) CN1079954A (cs)
AT (1) ATE150298T1 (cs)
AU (1) AU3362693A (cs)
BG (1) BG98933A (cs)
BR (1) BR9305674A (cs)
CA (1) CA2129027A1 (cs)
CZ (1) CZ182894A3 (cs)
DE (1) DE69309037T2 (cs)
DK (1) DK0624087T3 (cs)
ES (1) ES2099419T3 (cs)
FI (1) FI943550A7 (cs)
GB (1) GB9201857D0 (cs)
GR (1) GR3023142T3 (cs)
HU (1) HUT67462A (cs)
IL (1) IL104526A0 (cs)
MX (1) MX9300430A (cs)
NO (1) NO942813L (cs)
SK (1) SK91694A3 (cs)
WO (1) WO1993014747A1 (cs)
ZA (1) ZA93577B (cs)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030236236A1 (en) * 1999-06-30 2003-12-25 Feng-Jing Chen Pharmaceutical compositions and dosage forms for administration of hydrophobic drugs
GB9920148D0 (en) * 1999-08-25 1999-10-27 Smithkline Beecham Plc Novel composition
US6436990B1 (en) 1999-10-27 2002-08-20 Nobex Corporation 6-methoxy-2-naphthylacetic acid prodrugs
TWI262791B (en) 1999-10-27 2006-10-01 Nobex Corp 6-methoxy-2-naphthylacetic acid prodrugs
US6552078B2 (en) 1999-10-27 2003-04-22 Nobex Corp 6-methoxy-2-naphthylacetic acid prodrugs
US20020132010A1 (en) * 2000-12-22 2002-09-19 Yihong Qui Divalproex sodium dosage forms and a process for their production
US20040161474A1 (en) * 2002-05-24 2004-08-19 Moerck Rudi E. Rare earth metal compounds methods of making, and methods of using the same
US20060083791A1 (en) 2002-05-24 2006-04-20 Moerck Rudi E Rare earth metal compounds methods of making, and methods of using the same
US20040115287A1 (en) * 2002-12-17 2004-06-17 Lipocine, Inc. Hydrophobic active agent compositions and methods
ES2600577T3 (es) * 2003-12-04 2017-02-09 Bend Research, Inc. Procedimiento de pulverización-solidificación que usa un extrusor para preparar composiciones en multipartículas de fármacos cristalinos
WO2005053652A1 (en) 2003-12-04 2005-06-16 Pfizer Products Inc. Multiparticulate crystalline drug compositions containing a poloxamer and a glyceride
WO2005053639A2 (en) * 2003-12-04 2005-06-16 Pfizer Products Inc. Controlled release multiparticulates formed with dissolution enhancers
KR100844628B1 (ko) * 2003-12-04 2008-07-07 화이자 프로덕츠 인크. 제약상 다입자의 제조 방법
MXPA06005913A (es) * 2003-12-04 2006-06-27 Pfizer Prod Inc Formas de dosificacion de multiparticulas de azitromicina por procedimientos basados en liquidos.
EP1701702A1 (en) * 2003-12-04 2006-09-20 Pfizer Products Inc. Spray-congeal process using an extruder for preparing multiparticulate azithromycin compositions containing preferably a poloxamer and a glyceride
US6984403B2 (en) * 2003-12-04 2006-01-10 Pfizer Inc. Azithromycin dosage forms with reduced side effects
CA2547597A1 (en) * 2003-12-04 2005-06-16 Pfizer Products Inc. Multiparticulate compositions with improved stability
JP2008516971A (ja) * 2004-10-15 2008-05-22 アルテアーナノ，インコーポレーテッド 錠剤による負荷が軽減されるリン酸塩結合剤
AU2006279343A1 (en) * 2005-08-17 2007-02-22 Altairnano, Inc. Treatment of chronic renal failure and other conditions in domestic animals: compositions and methods
US7541384B2 (en) * 2007-06-08 2009-06-02 Axcan Pharma Inc. Mesalamine suppository
US8436051B2 (en) * 2007-06-08 2013-05-07 Aptalis Pharma Canada Inc. Mesalamine suppository
US8217083B2 (en) * 2007-06-08 2012-07-10 Aptalis Pharma Canada Inc. Mesalamine suppository
US11304960B2 (en) 2009-01-08 2022-04-19 Chandrashekar Giliyar Steroidal compositions
ES2871021T3 (es) 2010-05-12 2021-10-28 Spectrum Pharmaceuticals Inc Hidróxido de carbonato de lantano, oxicarbonato de lantano y procedimientos de fabricación y uso
US20180153904A1 (en) 2010-11-30 2018-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US9034858B2 (en) 2010-11-30 2015-05-19 Lipocine Inc. High-strength testosterone undecanoate compositions
US9358241B2 (en) 2010-11-30 2016-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US20120148675A1 (en) 2010-12-10 2012-06-14 Basawaraj Chickmath Testosterone undecanoate compositions
US9498485B2 (en) 2014-08-28 2016-11-22 Lipocine Inc. Bioavailable solid state (17-β)-hydroxy-4-androsten-3-one esters
WO2016033549A2 (en) 2014-08-28 2016-03-03 Lipocine Inc. (17-ß)-3-OXOANDROST-4-EN-17-YL TRIDECANOATE COMPOSITIONS AND METHODS OF THEIR PREPARATION AND USE
US20160361322A1 (en) 2015-06-15 2016-12-15 Lipocine Inc. Composition and method for oral delivery of androgen prodrugs
US11559530B2 (en) 2016-11-28 2023-01-24 Lipocine Inc. Oral testosterone undecanoate therapy
WO2020018974A1 (en) 2018-07-20 2020-01-23 Lipocine Inc. Liver disease

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4420639C1 (en) * 1973-09-11 2001-08-21 Beecham Group Ltd Aromatic compounds
GB1474377A (en) 1973-09-11 1977-05-25 Beecham Group Ltd Naphthalene derivatives
US4086346A (en) * 1974-04-06 1978-04-25 Bayer Aktiengesellschaft Preparation of melt-sprayed spherical phenacetin granules
DE3833446A1 (de) 1988-10-01 1990-04-05 Hoechst Ag Verfahren zur herstellung von arzneimittelwirkstoff-partikeln mit verbesserten fliess-, lager- und formulierungseigenschaften sowie arzneimittel, die diese arzneimittelwirkstoff-partikeln enthalten

Also Published As

Publication number Publication date
NO942813D0 (no) 1994-07-28
HU9402221D0 (en) 1994-09-28
FI943550A0 (fi) 1994-07-28
ZA93577B (en) 1994-01-13
MX9300430A (es) 1994-08-31
CA2129027A1 (en) 1993-08-05
AU3362693A (en) 1993-09-01
NO942813L (no) 1994-07-28
BR9305674A (pt) 2005-01-11
US5539000A (en) 1996-07-23
IL104526A0 (en) 1993-05-13
GR3023142T3 (en) 1997-07-30
CN1079954A (zh) 1993-12-29
EP0624087A1 (en) 1994-11-17
BG98933A (en) 1995-07-28
FI943550L (fi) 1994-07-28
WO1993014747A1 (en) 1993-08-05
ES2099419T3 (es) 1997-05-16
KR950700056A (ko) 1995-01-16
FI943550A7 (fi) 1994-07-28
GB9201857D0 (en) 1992-03-18
DE69309037D1 (de) 1997-04-24
HUT67462A (en) 1995-04-28
DK0624087T3 (da) 1997-09-01
EP0624087B1 (en) 1997-03-19
DE69309037T2 (de) 1997-07-24
JPH07503245A (ja) 1995-04-06
CZ182894A3 (en) 1995-02-15
ATE150298T1 (de) 1997-04-15

Similar Documents

Publication Publication Date Title
SK91694A3 (en) Spray-cooled nabumetone, method of its preparation and use
US4632843A (en) Process for the preparation of solid pharmaceutical products
CN113438944A (zh) 一种parp抑制剂微丸制剂及其制备工艺
JP2001517616A (ja) 活性成分としてクロドロン酸塩および賦形剤としてケイ化微晶質セルロースを含む医薬製剤
SK8022002A3 (en) Compressed tablet composition, process for the preparation thereof and its use
CA2371231A1 (en) Pharmaceutical composition in unit form containing acetylsalicylic acid and clopidogrel hydrogenosulphate
JP2006528221A (ja) ビカルタミドの形態、組成物、およびその製造方法
JP4856843B2 (ja) 新規フェノフィブラート錠剤
JP3180359B2 (ja) 錠剤様発泡性農薬組成物の製造法
CZ303694B6 (cs) Prípravek nesteroidního protizánetlivého léciva obsahující granulární a extragranulární kompozici a zpusob jeho prípravy
CN105106152A (zh) 一种盐酸决奈达隆组合物
JPH0691150A (ja) マスクされた粒状物
KR100358614B1 (ko) 푸시드산정제의제조방법
EP3288535B1 (en) Monensin water dispersible granules by wet granulation
EP2946771B1 (en) Water-dispersible tablet formulation comprising deferasirox
WO2001092268A1 (en) Process for drying amoxicillin
EP2526931B1 (en) Wet granulation methods of cetyl myristate and/or cetyl palmitate
SI9300045A (sl) Prsilno ohlajen nabumeton in postopek za njegovo izdelavo
KR100455797B1 (ko) 미립상 형태의 테트라히드로피리딘 유도체
CA2201040A1 (en) Solid pharmaceutical preparation, comprising 5-methylisoxazole-4-carboxylic acid (4-trifluoromethyl)anilide
EP3782621A1 (en) Instant release pharmaceutical preparation of anticoagulant and preparation method therefor
NO174453B (no) Fremgangsmaate for fremstilling av et bindemiddelfritt celiprolohydroklorid-granulat som kan tabletteres
EP2682104A1 (en) Orally-disintegrating formulations of dexketoprofen
EP2682105A1 (en) Orally-disintegrating formulations of dexketoprofen
EP0362731A2 (de) Verfahren zur Herstellung von Arzneimittelwirkstoff-Partikeln mit verbesserten Fliess-, Lager- und Formulierungseigenschaften sowie Arzneimittel, die diese Arzneimittelwirkstoff-Partikeln enthalten